BI 765423 - Boehringer Ingelheim
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment (clinicaltrials.gov) - Sep 26, 2026 - P2 | N=81 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting 
Enrollment closed • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
http://clinicaltrials.gov/ct2/show/NCT07036523
 
Sep 26, 2026
 
Prev Next